Pandemic-era NIH grants (FY2019-2024) covering coronavirus, gain-of-function research, mRNA vaccines, biosafety, and related funding flows. Metadata + abstracts from NIH RePORTER.
Get an AI answer drawn only from the NIH Pandemic-Era Grants documents indexed here — every claim cited back to the filing or proceeding it came from. It will tell you plainly when the record doesn't cover your question, rather than guessing.
Houjian Cai · UNIVERSITY OF GEORGIA · 2023 · $221,972 — Summary/Abstract SARS-CoV-2 has caused the deaths of millions of people globally. Effective antiviral therapeutic treatment options are urgently needed. CRISPR-mediated genome editing has provided a very promising avenue for treatment of a variety of genetic diseases. Particularly, the CRISPR-Cas13 …
Merav Socolovsky · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 2023 · $515,212 — Project Summary Protein synthesis and ribosome biogenesis are the two most energy -intensive processes in a cell, resulting in their regulation through tight controls. EpoR, a member of the cytokine receptor superfamily, and its downstream mediator Stat5, are essential for erythropoiesis. The curren…
WEI CHEN · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2023 · $195,000 — Abstract The long-term goal of our research is to develop effective therapies against SARS-CoV-2-elicited disease Covid-19. SARS-CoV-2 spike (S) protein binds to its cognate receptor, angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine proteas…
Irina Budunova · NORTHWESTERN UNIVERSITY AT CHICAGO · 2023 · $247,411 — COVID-19 continues to be a global catastrophe despite development of anti-SARS-CoV-2 vaccines. This is due to the worldwide limited vaccine availability, vaccination hesitancy, and the emergence of new variants of SARS- CoV-2. Moreover, there is a lack of complete knowledge about SARS-CoV-2 biology,…
Matthew Bogyo · STANFORD UNIVERSITY · 2023 · $236,100 — Project Summary Current strategies to overcome virus outbreaks are focused on development of effective vaccines as well as novel treatments that can either block infection or prevent mortality from the resulting disease. One of the strategies that has shown promise is the use of serum from patients …
YUPING WANG · LOUISIANA STATE UNIV HSC SHREVEPORT · 2023 · $219,000 — COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged as the greatest threat to global health and significantly impact pregnant women worldwide. COVID-19 infection during pregnancy is associated with substantial risk of increases in maternal morbidity and mort…
WEN-YUAN E HSIEH · UNIVERSITY OF COLORADO DENVER · 2023 · $613,169 — PROJECT SUMMARY Emergence of the highly transmissible SARS-CoV-2 B.1.617.2 (Delta) variant and return to in-person learning is rapidly increasing the COVID-19 disease incidence and transmission rate in children. Therefore, it is critical to protect younger children. Toward this goal, ongoing COVID-1…
Ariel Jade Kuhn · UNIVERSITY OF WISCONSIN-MADISON · 2023 · $68,684 — PROJECT SUMMARY Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the etiological agent of coronavirus disease (COVID-19), has spurred an unprecedented global pandemic. Infection surges necessitate new therapeutic agents that are effective against a rapidly changing virus. Antiviral…
Ricardo Rajsbaum · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · 2023 · $471,011 — The Severe Acute Respiratory Syndrome Coronavirus 2 (CoV-2) belongs to a family of pathogenic enveloped RNA viruses of the family Coronaviridae. The ongoing pandemic has caused a public health emergency worldwide, accompanied by dire health and economic consequences. There is evidence suggesting tha…
CHRISTOPHER M WATERS · UNIVERSITY OF KENTUCKY · 2023 · $232,586 — Acute lung injury and its more severe form, acute respiratory distress syndrome (ARDS), are devastating illnesses with high rates of incidence and mortality. Patients with acute lung injury are typically provided supplemental oxygen using positive pressure mechanical ventilation, but this can lead t…
YAN XIANG · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2023 · $193,750 — Summary The novel coronavirus SARS-CoV-2 causes the COVID-19 pandemic. The virus infects through the respiratory tracts. While most COVID-19 patients display no or mild clinical symptoms, a small percentage develop severe immune-mediated pathological complications, which could lead to injury and fai…
Jack T. Stapleton · IOWA CITY VA MEDICAL CENTER · 2023 — We propose to characterize SARS-CoV-2 interactions with human T cells and examine how this influences adaptive and humoral immunity. SARS-CoV-2 (CoV2) is the etiologic agent of COVID-19, the third highly pathogenic coronavirus to emerge as a human pathogen since 2000. CoV-2 causes disease by dysregu…
Zhenyu Zhong · UT SOUTHWESTERN MEDICAL CENTER · 2023 · $410,000 — Project Summary A balanced supply of deoxynucleoside triphosphates (dNTPs), the building blocks for DNA, is vital for the synthesis or repair of both nuclear and mitochondrial genomes, whereas its imbalance results in genome instability that precipitates cellular damage and breach of homeostasis. Re…
Asrar B. Malik · UNIVERSITY OF ILLINOIS AT CHICAGO · 2023 · $739,004 — PROJECT SUMMARY / ABSTRACT Coronavirus disease 2019 (COVID-19) is a devastating systemic inflammatory syndrome caused by the coronavirus SARS-CoV-2 which has resulted in over 500,000 deaths in the US during the past year, with this high rate of mortality being attributed in large part to the develop…
Weishan Huang · LOUISIANA STATE UNIV A&M COL BATON ROUGE · 2023 · $203,149 — Project Summary/Abstract SARS-CoV-2, the etiological pathogen of COVID-19, has resulted in a pandemic. There remains an urgent need for innovative technologies which facilitate the development of affordable antiviral precision medicine. SARS-CoV-2 is an enveloped virus, and the structure of the tri…
Harris H Wang · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2023 · $452,375 — PROJECT SUMMARY The ability to synthesize gene- and pathway-sized DNA is a key tool in functional genomics. Many applications of gene synthesis call for the generation and testing of sequence variants containing multi-site mutations. Unfor- tunately, current approach to produce such constructs still…
HAFIZ AHMED · GLYCOMANTRA, INC. · 2023 · $296,637 — Project Summary/Abstract The COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), is a global pandemic with catastrophic consequences for healthcare systems and populations. The increased morbidity and mortality in older persons and those with diabetes (12-22%) and h…
Chandan Guha · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2023 · $682,293 — Abstract Radiation-Induced Immune Dysfunction (RIID) is a critical component of both acute and delayed effects of radiation exposure, which causes a multi-organ failure (MOF) syndrome, operationally divided based upon timing of clinical manifestations, as acute radiation syndrome (ARS) and delayed e…
Elke BergmannLeitner · THOMAS JEFFERSON UNIVERSITY · 2023 · $170,141 — PROJECT SUMMARY As COVID-19 pandemic continues with the evolution of new strains, we acknowledge the groundwork that has been done evaluating maternal immunity following COVID-19 vaccine or disease exposure in pregnancy, and passive transmission of antibodies in cord blood and breastmilk. There rema…
EDWARD D CHAN · VA EASTERN COLORADO HEALTH CARE SYSTEM · 2023 — The clinical outcome for patients with severe COVID-19 remains poor due to the lack of highly efficacious treatment for such individuals. Finding a better remedy for them is an important niche and immediate unmet need. The aim of this pre-clinical project is to substantiate the therapeutic effect of…